United Therapeutics Corporation Net Fee Amt
United Therapeutics Corporation (UTHR) had Net Fee Amt of $115.10 thousand as of 2026-07-09, per its S-8 filed 2026-07-13.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-07-13
- 2026-07-09: Net Fee Amt $115.10K.
| Period end | Net Fee Amt |
|---|---|
| 2026-07-09 | $115.10K S-8 · filed 2026-07-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |